ACANTHAMOEBA KERATITIS
Clinical trials for ACANTHAMOEBA KERATITIS explained in plain language.
Never miss a new study
Get alerted when new ACANTHAMOEBA KERATITIS trials appear
Sign up with your email to follow new studies for ACANTHAMOEBA KERATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Green light and rose dye show promise for blinding eye infections
Disease control CompletedThis study tested whether adding a special light treatment (rose Bengal plus green light) to standard antibiotic or antifungal eye drops could improve vision after 6 months in people with severe corneal infections. 330 adults in India and Brazil with fungal, amoeba, or other seri…
Matched conditions: ACANTHAMOEBA KERATITIS
Phase: PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for rare eye infection: treatment trial compares drug combinations
Disease control CompletedThis study looked at the best way to treat acanthamoeba keratitis, a rare but serious eye infection caused by a parasite. 49 people took part and were first given either chlorhexidine alone or chlorhexidine plus povidone iodine. Later, some received corticosteroids early, some la…
Matched conditions: ACANTHAMOEBA KERATITIS
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New hope for rare eye infection: eye drops show promise in study
Disease control CompletedThis study looked back at medical records of 40 people with a rare, serious eye infection called acanthamoeba keratitis. All patients received a special eye drop (0.8 mg/ml polihexanide) as part of a compassionate use program. The goal was to see how many patients were cured, mea…
Matched conditions: ACANTHAMOEBA KERATITIS
Sponsor: SIFI SpA • Aim: Disease control
Last updated May 13, 2026 16:03 UTC